)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Cardiff Oncology
Cardiff Oncology (CRDF) investor relations material
Cardiff Oncology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary23 Apr, 2026
Executive summary
Annual meeting scheduled for June 11, 2026, at company headquarters in San Diego, CA.
Shareholders will vote on four key proposals, including director elections and executive compensation.
Proxy materials and the 2025 Annual Report are available online, with options for paper or email copies upon request.
Voting matters and shareholder proposals
Election of six directors: Dr. James O. Armitage, Dr. Rodney Markin, Mani Mohindru, Ph.D., Gary W. Pace, Ph.D., Renee P. Tannenbaum, and Låle White.
Ratification of BDO USA, P.C. as independent registered public accountants for fiscal year ending December 31, 2026.
Approval of an amendment to the 2021 Omnibus Equity Incentive Plan, increasing shares issuable to 15,150,000 from 12,150,000.
Advisory vote on the compensation of named executive officers.
Board recommends voting "FOR" all nominees and proposals.
Board of directors and corporate governance
Six director nominees are presented for election at the annual meeting.
Dr. Rodney S. Markin serves as Chairman of the Board.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cardiff Oncology
- Annual meeting covers director elections, auditor ratification, equity plan amendment, and say-on-pay.CRDF
Proxy filing23 Apr 2026 - Onvansertib plus FOLFIRI+BEV achieved a 72% response rate and strong PFS in RAS mutated CRC.CRDFKOL event25 Mar 2026
- Onvansertib shows 72% ORR and robust PFS in RAS-mutated mCRC, advancing to phase III trials.CRDFOppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026
- Strong Phase 2 results in RAS-mutated mCRC drive registrational plans and extend cash runway.CRDFQ4 202525 Feb 2026
- Onvansertib delivers strong response rates and safety in first-line RAS-mutated mCRC, advancing to phase 3.CRDFStifel 2025 Healthcare Conference3 Feb 2026
- Onvansertib plus FOLFIRI-Bev showed 72.2% ORR and extended PFS in RAS-mutated mCRC.CRDFStudy result2 Feb 2026
- Q2 net loss was $11.8M; cash reserves of $60.3M support operations through Q3 2025.CRDFQ2 20242 Feb 2026
- Onvansertib shows strong efficacy in first-line RAS-mutated colorectal cancer, with pivotal trials underway.CRDFJefferies 2024 Global Healthcare Conference31 Jan 2026
- Onvansertib delivers high response rates and deep tumor regression in first-line RAS-mutated mCRC.CRDFCompany presentation27 Jan 2026
Next Cardiff Oncology earnings date
Q1 202621 May, 2026
Cardiff Oncology
Next Cardiff Oncology earnings date
Q1 202621 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage